MEOX1 and ovarian cancer: In laryngeal cancer, silencing of HOXC6 inhibits EMT, viability, migration, and invasion of laryngeal cancer cells, thereby suppressing laryngeal cancer LNM.472 Li et al. demonstrated that MEOX1 promotes LNM in ovarian cancer by regulating multiple biological processes, including proliferation, EMT, lymphangiogenesis, and ECM remodeling.